Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD
Not Applicable
Completed
- Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Interventions
- Behavioral: RecommendationBehavioral: Choice
- Registration Number
- NCT00631280
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Brief Summary
The purpose of the study is to determine whether active parent involvement in deliberation and choice improves subsequent medication persistence for their child with ADHD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
- Diagnosed with ADHD based on DSM-IV criteria
- Enrolled in school-setting
- No learning disability
- No past use of psychoactive medication
Exclusion Criteria
- Do not meet DSM-IV criteria for ADHD
- Not enrolled in school-setting
- Presence of learning disability
- History of brain injury
- Past use of psychoactive medication
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Recommendation Recommendation - Choice Choice -
- Primary Outcome Measures
Name Time Method Number of days covered with medication as determined by pharmacy refill records one year
- Secondary Outcome Measures
Name Time Method Decisional Conflict immediately after intervention or control condition delivered Decisional Regret immediately after intervention or control condition delivered Satisfaction with Information about Medicine immediately after intervention or control condition delivered Working Alliance Inventory immediately after intervention or control condition delivered
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does active parent involvement in ADHD medication decisions affect dopamine transporter expression or neural circuitry in pediatric patients?
What is the comparative effectiveness of parent-led choice versus standard stimulant therapy in ADHD medication adherence?
Which biomarkers, such as DAT1 or DRD4 polymorphisms, predict response to behavioral intervention in ADHD treatment persistence?
What adverse events are associated with parent involvement in ADHD pharmacotherapy decision-making and how are they managed?
How does combining parent-deliberation strategies with methylphenidate or atomoxetine impact long-term ADHD treatment outcomes?
Trial Locations
- Locations (1)
Cincinnati Children's Hospital Medical Center
🇺🇸Cincinnati, Ohio, United States